Loading…
Loading the latest PSX data…
Loading the latest PSX data…
BF Biosciences Limited (BFBIO) against the KSE-100 index: performance, valuation, growth, risk and danioPSX score, side by side.
Add a stock
Growth of Rs 100 from 2025-11-11
Daily closes from PSX end-of-day files, adjusted for bonus shares, right issues and splits (not for cash dividends). KSE-100: official closes where available, otherwise rebuilt from its constituents.
| Measure | BFBIOPharmaceuticals |
|---|---|
| danioPSX score | 44 |
| Price and size | |
| Price | Rs 136.13 |
| Today | +0.64% |
| Market cap | Rs 12.0bn |
| Traded per day | Rs 16m |
| Valuation and dividends | |
| P/E | 18.3 |
| Dividend yield | – |
| EPS (last year) | Rs 7.16 |
| Business | |
| EPS growth | +29.7% |
| Sales growth | +62.1% |
| Net margin | 6.7% |
| Returns | |
| 1 month | +4.8% |
| 3 months | +0.1% |
| 1 year | −10.1% |
| vs KSE-100, 1 year | -23.2 pts |
| Trend and risk | |
| 52-week position | 31% |
| RSI 14 | 66 |
| RS rank | 47 |
| Volatility | 36% |
| Beta | 0.96 |
| danioPSX score | |
| Value | 27 |
| Quality | 67 |
| Dividend | 0 |
| Momentum | 46 |
| Safety | 74 |
| Shariah-compliant | Yes |
Bold marks the best value in each row where higher (or, for P/E and volatility, lower) is clearly better.
A comparison of published numbers, not a recommendation. Share this page: the address holds the stocks. Find more stocks with the screener